Normal cell phenotypes of breast epithelial cells provide the foundation of a breast cancer taxonomy

Expert Review of Anticancer Therapy

Volumn 14, Issue 12, 2014, Pages 1385-1389

  Santagata, Sandro ^a,b   Ince, Tan A ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

omics; biomarkers; breast cancer diagnostics; heterogeneity; Nurses' Health Study; pathology

Indexed keywords

ANDROGEN RECEPTOR; CYTOKERATIN 14; CYTOKERATIN 5; ESTROGEN RECEPTOR; TUMOR MARKER; VITAMIN D RECEPTOR;

BREAST CANCER; BREAST CELL; BREAST EPITHELIUM; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER SURVIVAL; CELL DIFFERENTIATION; DISEASE ONTOLOGY; EPITHELIUM CELL; GOLD STANDARD; HUMAN; PREDICTIVE VALUE; PROTEIN EXPRESSION; REVIEW; TAXONOMY; TRIPLE NEGATIVE BREAST CANCER; TUMOR DIFFERENTIATION; BREAST TUMOR; CLASSIFICATION; FEMALE; PATHOLOGY; PHENOTYPE;

BREAST NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; PHENOTYPE;

EID: 84911938907     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.2014.956096     Document Type: Review

References (16)

1. Prat A, Parker JS, Karginova O, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010;12: R68
2. Prat A, Perou CM. Deconstructing the molecular portraits of breast cancer. Mol Oncol 2010;5:5-23
3. TCGA. Comprehensive molecular portraits of human breast tumours. Nature 2012;490: 61-70
4. Curtis C, Shah SP, Chin SF, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012;486:346-52
5. Dawson SJ, Rueda OM, Aparicio S, Caldas C. A new genome-driven integrated classification of breast cancer and its implications. EMBO J 2013;32:617-28
6. Yaffe MB. The scientific drunk and the lamppost: massive sequencing efforts in cancer discovery and treatment. Sci Signal 2013;6:pe13
7. Guiu S, Michiels S, Andre F, et al. Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. Ann Oncol 2012;23:2997-3006
8. Schnitt SJ. Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol 2010; 23(Suppl 2):S60-4
9. Santagata S, Thakkar A, Ergonul A, et al. Taxonomy of breast cancer based on normal cell phenotype predicts outcome. J Clin Invest 2014;124:859-70
10. Swerdlow S, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer; Lyon, France: 2008
11. Jones C, Mackay A, Grigoriadis A, et al. Expression profiling of purified normal human luminal and myoepithelial breast cells identification of novel prognostic markers for breast cancer. Cancer Res 2004;64:3037-45
12. Molyneux G, Geyer FC, Magnay FA, et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 2010;7:403-17
13. Gusterson B. Do 'basal-like' breast cancers really exist? Nat Rev Cancer 2009;9:128-34
14. Gusterson BA, Ross DT, Heath VJ, Stein T. Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer. Breast Cancer Res 2005;7:143-8
15. Gerdes MJ, Sevinsky CJ, Sood A, et al. Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue. Proc Natl Acad Sci USA 2013;110: 11982-7
16. Harrell JC, Prat A, Parker JS, et al. Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. Breast Cancer Res Treat 2012;132:523-35